389 related articles for article (PubMed ID: 35996244)
21. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
Fox BP; Tabone CJ; Kandpal RP
Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
[TBL] [Abstract][Full Text] [Related]
22. Differential gene expression of Eph-ephrin A1 and LEPR-LEP with high or low number of embryos in pigs during implantation.
Fu Y; Knox RV; Li L; Ren S
Reprod Domest Anim; 2018 Aug; 53(4):937-946. PubMed ID: 29740882
[TBL] [Abstract][Full Text] [Related]
23. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
[TBL] [Abstract][Full Text] [Related]
24. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
[TBL] [Abstract][Full Text] [Related]
25. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread.
Pergaris A; Danas E; Goutas D; Sykaras AG; Soranidis A; Theocharis S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445116
[TBL] [Abstract][Full Text] [Related]
26. ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
Ieguchi K; Tomita T; Omori T; Komatsu A; Deguchi A; Masuda J; Duffy SL; Coulthard MG; Boyd A; Maru Y
Oncogene; 2014 Apr; 33(17):2179-90. PubMed ID: 23686306
[TBL] [Abstract][Full Text] [Related]
27. Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2.
Aasheim HC; Delabie J; Finne EF
Blood; 2005 Apr; 105(7):2869-76. PubMed ID: 15585656
[TBL] [Abstract][Full Text] [Related]
28. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
29. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
30. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
[TBL] [Abstract][Full Text] [Related]
31. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
[TBL] [Abstract][Full Text] [Related]
33. Eph/Ephrin Signaling in the Tumor Microenvironment.
Ieguchi K; Maru Y
Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
[TBL] [Abstract][Full Text] [Related]
34. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
35. Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.
Fujiwara H; Nishioka Y; Matsumoto H; Suginami K; Horie A; Tani H; Matsumura N; Baba T; Sato Y; Araki Y; Konishi I
Int J Gynecol Cancer; 2013 Mar; 23(3):576-82. PubMed ID: 23429488
[TBL] [Abstract][Full Text] [Related]
36. Regulation and misregulation of Eph/ephrin expression.
Arvanitis DN; Davy A
Cell Adh Migr; 2012; 6(2):131-7. PubMed ID: 22568953
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
38. Architecture of Eph receptor clusters.
Himanen JP; Yermekbayeva L; Janes PW; Walker JR; Xu K; Atapattu L; Rajashankar KR; Mensinga A; Lackmann M; Nikolov DB; Dhe-Paganon S
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10860-5. PubMed ID: 20505120
[TBL] [Abstract][Full Text] [Related]
39. Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.
Makarov A; Ylivinkka I; Nyman TA; Hyytiäinen M; Keski-Oja J
Cell Biol Int; 2013 Oct; 37(10):1080-8. PubMed ID: 23686814
[TBL] [Abstract][Full Text] [Related]
40. Receptor-binding domain of ephrin-A1: production in bacterial expression system and activity.
Nekrasova OV; Sharonov GV; Tikhonov RV; Kolosov PM; Astapova MV; Yakimov SA; Tagvey AI; Korchagina AA; Bocharova OV; Wulfson AN; Feofanov AV; Kirpichnikov MP
Biochemistry (Mosc); 2012 Dec; 77(12):1387-94. PubMed ID: 23244735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
